Skip to content

Comparison of AWBAT™-D and MEPILEX® AG for Treatment of Donor Sites in Burn Surgery

A Randomized, Prospective Comparison of AWBAT™-D and MEPILEX® AG for Treatment of Donor Sites in Burn Surgery

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00974597
Enrollment
30
Registered
2009-09-10
Start date
2009-09-30
Completion date
Unknown
Last updated
2010-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn Surgery

Keywords

burn, donor site, treatment of burns, Treatment of Donor Sites

Brief summary

The purpose of this study is to examine AWBAT™-D compared to Mepilex® Ag for the treatment of donor sites in burn surgery.

Interventions

DEVICEAWBAT™-D and Mepilex® Ag dressings

Comparison of AWBAT™-D and Mepilex® Ag dressings for treatment of donor sites in burn surgery.

Sponsors

Aubrey Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Burn wounds requiring skin grafting * Matched donor sites available * 1-30% TBSA

Exclusion criteria

* Severe inhalation injury * Pregnancy * Co-morbidity which may compromise healing * Known allergy to pork or pork products

Design outcomes

Primary

MeasureTime frame
Compare rate of healing of donor sites6 month follow-up

Secondary

MeasureTime frame
Compare complication rates6 month follow-up
Compare patient reported perception of pain6 month follow-up
Compare clinical outcome (scarring)6 month follow-up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026